Compare Stocks

Alaska Hydro Corporation engages in the development of renewable energy projects. It primarily focuses on hydroelectric power generation for resource development. The company is involved in the development of the More Creek hydroelectric project with a generation capacity of approximately 306 gigawatt hours of energy per year located in northwest British Columbia. Alaska Hydro Corporation is headquartered in North Vancouver, Canada.

Artio Global Investors Inc. (Investors) is an asset management company. Investors provide investment management services to institutional and mutual fund clients. The Company also offers select group of other equity and fixed income strategies, including High Grade Fixed Income, High Yield, International Equity and Global Equity. As of December 31, 2012, the Company managed six different investment strategies across five asset classes: High Grade Fixed Income; High Yield, International Equity, Global Equity,and Emerging Markets Local Debt. The Company's primary business objective is to consistently generate investment returns for its clients. As of December 31, 2012, its International Equity strategies including High Grade Fixed Income, High Yield, 9International Equity and Global Equity. In May 2013, Aberdeen Asset Management Plc completed the acquisition of Artio Global Investors Inc.

Asterias Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing cell-based therapeutics to treat neurological conditions associated with demyelination, and cellular immunotherapies to treat cancer. Its clinical stage programs include AST-OPC1, an oligodendrocyte progenitor cell population derived from pluripotent stem cells that is in Phase I/IIa clinical trial for spinal cord injuries; AST-VAC2 is a non-patient-specific cancer immunotherapy derived from pluripotent stem cells for the treatment of non-small cell lung cancer; and AST-VAC1, a patient-specific cancer immunotherapy that has completed Phase II clinical trial for the treatment of acute myeloid leukemia. The company was formerly known as BioTime Acquisition Corporation and changed its name to Asterias Biotherapeutics, Inc. in March 2013. Asterias Biotherapeutics, Inc. was founded in 2012 and is headquartered in Fremont, California.

Orbital Infrastructure Group, Inc. engages in the acquisition, development and commercialization of electro-mechanical products and technologies worldwide. It operates through the following segments: Electric Power, Telecommunications and Renewables. The Electric Power segment provides comprehensive infrastructure solutions to customers in the electric power industry. The Telecommunications segment provides enterprise solutions to the cable and telecommunication industries. The Renewables segment focuses on utility-scale solar construction. The company was founded on April 21, 1998 and is headquartered in Houston, TX.